New Nordic Healthbrands AbOMXSTO: NNH

NNH: Q1 2026 saw a 7.9% sales decline and a net loss, but growth in the Nordics and Rest of World

· Issued by New Nordic Healthbrands AB

Net sales declined 7.9% year-over-year in Q1 2026, with losses driven by weaker sales in North America and the UK, while the Nordic region and Rest of World saw growth. Gross margin fell to 62.4%, and the company expects improvement in Q2.

Original document:

This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.

Company analysis

Earlier from New Nordic Healthbrands Ab

All New Nordic Healthbrands Ab news releases